Abstract
Fertility preservation in cancer patients is an increasingly relevant challenge due to the gonadotoxic effects of conventional treatments, such as chemotherapy and radiotherapy. This article reviews current options for fertility preservation and explores the potential of DEX immunotherapy as a less invasive alternative. Initially, an overview of cancer incidence in fertile age and the importance of addressing reproductive concerns in this population group is presented. Subsequently, the negative impacts of conventional treatments on reproductive capacity are analyzed and strategies to minimize these risks, such as reducing treatment intensity and using cryopreservation techniques, are discussed DEX immunotherapy stands out as a promising option, with a lower risk of gonadotoxicity compared to traditional treatments. This immunological approach allows to specifically target cancer cells, reducing damage to reproductive cells and offering better fertility preservation in young patients. Finally, the article addresses future research needs and practical guidelines for clinicians, highlighting the importance of a multidisciplinary approach that integrates fertility preservation options in cancer treatment. It is concluded that, although DEX immunotherapy is a viable alternative, it is essential to promote further research and develop specific clinical protocols to maximize its effectiveness and safety in terms of long-term reproductive health
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call